AI-generated summary. We recommend consulting the bill text for important decisions.

Utah's "Right to Try" law allows seriously ill patients to access experimental drugs and medical devices that have passed initial FDA safety testing but haven't yet received full approval. This bill expands that law in several ways: it creates a new category called "eligible illness" — meaning a severely debilitating condition where a doctor determines conventional treatments are unsatisfactory — so that patients with serious but non-terminal conditions can now also access investigational treatments; it broadens the definition of "terminal illness" to explicitly include cancer as diagnosed by a board-certified oncologist; it updates the list of allowable drug forms to include any liquid formulation (not just suspensions); and it requires manufacturers who provide investigational drugs or devices to Utah patients under the eligible illness category to report to a legislative committee on how many patients were treated, what conditions were treated, and any adverse outcomes.